Dr Machaalani on the potential role of circulating KIM-1 as a biomarker in metastatic RCC
Published in OncLive, 2025
Discussion on the emerging role of circulating KIM-1 as a biomarker in metastatic renal cell carcinoma.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)